Pharma Commercial Mock
IQVIA™
Connected Intelligence™
National Prescription Audit
Source: NPA Weekly · Refresh: 2026-10-30·Marten Veskimae
Brand-level trends · ZENVARA™

Weekly NPA dashboard · southeast

TRx (week)
430▼ 10.0%
vs WK29, 2026-10-30
NRx (week)
131▼ 12.7%
vs prior week
NBRx (week)
27▼ 12.9%
new-to-brand
Cumulative TRx
5,923
12-week window
📈TRx — plan vs actual
022044066008-1408-2809-1109-2510-0910-23
Plan Actual
📊NRx ⨉ NBRx trend
08-1408-2809-1109-2510-0910-23
NRx NBRx
🍩Channel mix
RETAIL33%MAIL60%LTC7%
🗺️Geography — variance vs plan
WestMidwestNortheastSoutheast
Variance vs plan — darker = worse. Northeast highlighted as primary deviation region.
Weekly detail · 12 weeks
Week EndingTRxNRxNBRxPlan TRxVar %Cum TRx
2026-08-1452515238595-11.8%525
2026-08-2154015441596-9.4%1,065
2026-08-2847013533597-21.3%1,535
2026-09-0447414334598-20.7%2,009
2026-09-1150314635598-15.9%2,512
2026-09-1849115035599-18.0%3,003
2026-09-2551316135599-14.4%3,516
2026-10-0247913932599-20.0%3,995
2026-10-0951314832599-14.4%4,508
2026-10-1650715333599-15.4%5,015
2026-10-2347815031600-20.3%5,493
2026-10-3043013127600-28.3%5,923
© 2026 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union and various other countries. NPA™, Xponent™ and Connected Intelligence™ are trademarks of IQVIA Inc. This view is a demo mock and is not affiliated with IQVIA.